Acadia Pharmaceuticals annual revenue surpasses 1 billion dollars at Nasdaq bell ceremony

Acadia Pharmaceuticals annual revenue surpasses 1 billion dollars at Nasdaq bell ceremony
Acadia hits 1B revenue milestone

Acadia Pharmaceuticals has exceeded 1 billion dollars in annual revenue for the first time, marking a significant milestone celebrated with the ringing of the Opening Bell at the Nasdaq Exchange.

The company highlighted continued progress in transforming scientific innovations into new therapies, underscoring its commitment to growth and advancement in the pharmaceutical sector.

Acadia’s achievement follows a series of strategic engagements in the sector, including its participation at the Stifel 2026 Virtual CNS Forum to address advancements in central nervous system therapies and a presence at the ACMG Annual Clinical Genetics Meeting in Baltimore, where the company showcased its commitment to genetic research. These initiatives highlight Acadia’s broader effort to drive innovation alongside sustained financial momentum.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.